| Literature DB >> 30093418 |
Karl-Dimiter Bissig1, Weiguo Han2, Mercedes Barzi2, Nataliia Kovalchuk2, Liang Ding2, Xiaoyu Fan2, Francis P Pankowicz2, Qing-Yu Zhang2, Xinxin Ding1.
Abstract
Preclinical evaluation of drug candidates in experimental animal models is an essential step in drug development. Humanized mouse models have emerged as a promising alternative to traditional animal models. The purpose of this mini-review is to provide a brief survey of currently available mouse models for studying human xenobiotic metabolism. Here, we describe both genetic humanization and human liver chimeric mouse models, focusing on the advantages and limitations while outlining their key features and applications. Although this field of biomedical science is relatively young, these humanized mouse models have the potential to transform preclinical drug testing and eventually lead to a more cost-effective and rapid development of new therapies.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30093418 PMCID: PMC6199624 DOI: 10.1124/dmd.118.083303
Source DB: PubMed Journal: Drug Metab Dispos ISSN: 0090-9556 Impact factor: 3.922